Lipoatrophy is the term describing the localized loss of fat tissue. This may occur as a result of subcutaneous injections of insulin in the treatment of
diabetes
Diabetes, also known as diabetes mellitus, is a group of metabolic disorders characterized by a high blood sugar level (hyperglycemia) over a prolonged period of time. Symptoms often include frequent urination, increased thirst and increased ...
, from the use of
human growth hormone or from subcutaneous injections of
copaxone used for the treatment of
multiple sclerosis. In the latter case, an injection may produce a small dent at the injection site. Lipoatrophy occurs in
HIV-associated lipodystrophy
HIV-associated lipodystrophy is a condition characterized by loss of subcutaneous fat associated with infection with HIV.
Presentation
HIV-associated lipodystrophy commonly presents with fat loss in face, buttocks, arms and legs.
There is also ...
, one cause of which is an
adverse drug reaction that is associated with some
antiretroviral medications.
A more general term for an abnormal or degenerative condition of the entire body's
adipose tissue is ''
lipodystrophy
Lipodystrophy syndromes are a group of genetic or acquired disorders in which the body is unable to produce and maintain healthy fat tissue. The medical condition is characterized by abnormal or degenerative conditions of the body's adipose tissue. ...
''.
References
External links
Symptoms and signs
{{Symptom-stub